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The Brucella abortus type IV secretion system (T4SS), encoded by the virB operon, is essential for establishing
persistent infection in the murine reticuloendothelial system. To gain insight into the in vivo interactions
mediated by the T4SS, we compared host responses elicited by B. abortus with those of an isogenic mutant in
the virB operon. Mice infected with the B. abortus virB mutant elicited smaller increases in serum levels of
immunoglobulin G2a, gamma interferon (IFN-), and interleukin-12p40 than did mice infected with wild-type
B. abortus. Despite equal bacterial loads in the spleen, at 3 to 4 days postinfection, levels of IFN- were higher
in mice infected with wild-type B. abortus than in mice infected with the virB mutant, as shown by real-time
PCR, intracellular cytokine staining, and cytokine levels. IFN--producing CD4 T cells were more abundant in
spleens of mice infected with wild-type B. abortus than in virB mutant-infected mice. Similar numbers of IFN--
secreting CD8 T cells were observed in the spleens of mice infected with B. abortus 2308 or a virB mutant. These
results suggest that early differences in cytokine responses contribute to a stronger Th1 polarization of the immune
response in mice infected with wild-type B. abortus than in mice infected with the virB mutant.
Brucella abortus is an intracellular pathogen that resides
mainly in phagocytic cells and causes disease in animals and
humans (3, 43). The infection in both natural and incidental
host species is characterized by bacterial persistence in the
reticuloendothelial system. This persistent phase of the infec-
tion can be studied in the mouse model, which has been used
to identify virulence mechanisms used by Brucella spp. to es-
tablish persistence (15, 17, 22, 31, 32).
Protection against B. abortus infection is thought to be me-
diated primarily by a Th1 type of immune response (1, 44). B.
abortus triggers host antigen-presenting cells to release inter-
leukin-12 (IL-12), which causes Th0 cells to differentiate into
gamma interferon (IFN-)-secreting Th1 cells that are capable
of activating macrophage microbicidal mechanisms (25, 44). In
vitro and in vivo studies using mouse or murine macrophages
have shown that infection with Brucella spp. triggers the pro-
duction of IL-6, IL-1, and tumor necrosis alpha, whereas in
humans, IL-1, IL-6, and IL-8, but not tumor necrosis alpha, are
produced during infection (5, 11, 28). While IFN- and IL-12
promote the control of Brucella replication in the mouse, IL-10
decreases the ability of mice to control infections with B. abor-
tus (12, 33).
The type IV secretion system (T4SS) encoded by the virB
operon is essential for establishing persistent infection by Bru-
cella spp. in mice (10, 17, 35, 38). In addition, it has been shown
to contribute to intracellular survival in in vitro models of
infection by allowing the vacuole containing Brucella spp. to
exclude lysosomal proteins and associate with the exit sites of
the endoplasmic reticulum (6–9). This endoplasmic reticulum-
associated compartment appears to be the preferred niche for
the intracellular replication of Brucella spp. Although it is
widely thought that the formation of the replicative niche for
Brucella requires the translocation of effector proteins into the
host cell that interfere with vacuolar trafficking, no secreted
effectors of the T4SS have been identified to date.
Our knowledge about how Brucella spp. persist in the host in
the face of an active immune response to the bacteria is lim-
ited. In particular, the relationship between T4SS-mediated
intracellular survival and replication in vitro and persistence in
the reticuloendothelial system in vivo is unclear. B. abortus
mutants lacking an intact T4SS are initially able to colonize the
spleens of mice during the first 3 days after infection at the
same levels as those of wild-type bacteria (31, 32). Further-
more, while B. abortus infection results in the early activation
of host genes involved in inflammation and immunity, mutants
lacking a functional T4SS do not trigger this response (32). To
gain further insight into how the T4SS affects the host response
to infection, we characterized serum antibody and cytokine
responses to B. abortus 2308, a wild-type strain, and an isogenic
virB mutant. The results of these studies showed that while
infection with wild-type B. abortus elicits a Th1 type of immune
response, this polarization is decreased in mice infected with a
mutant lacking a functional T4SS.
MATERIALS AND METHODS
Bacterial strains, media, and culture conditions. Bacterial strains used in this
study were Brucella abortus wild-type strain 2308 and its isogenic mutant strain
BA41 (17), which has an insertion of mTn5Km2 at nucleotide 1232 of the B.
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abortus virB locus (GenBank accession number AF226278). This insertion is
located 59 bp downstream of the virB1 gene and is polar upon the expression of
downstream genes in the virB operon (39). Strains were cultured on tryptic soy
agar (Difco/Becton-Dickinson, Sparks, MD) or in tryptic soy broth at 37°C on a
rotary shaker. Bacterial inocula for infection of mice were cultured on tryptic soy
agar plus 5% blood (2). For cultures of strain BA41, kanamycin (Km) was added
to the culture medium at 100 mg/liter. All work with live B. abortus cells was
performed at biosafety level 3.
Infection of mice. Female C57BL/6 mice were obtained from the Jackson
Laboratory (Bar Harbor, ME) and were used at the age of 6 to 8 weeks. Mice
were held in microisolator cages with sterile bedding and water and irradiated
feed in a biosafety level 3 facility. Groups of 5 to 10 mice were inoculated
intraperitoneally (i.p.) with 0.1 ml of phosphate-buffered saline (PBS) containing
5  105 cells of a B. abortus wild-type strain or an isogenic virB mutant. All
animal experiments were approved by the Texas A&M University and University
of California Laboratory Animal Care and Use Committees and were conducted
in accordance with institutional guidelines.
Multiplex cytokine assays. Detection of specific cytokines in the serum or
spleens of C57BL/6 mice was performed using Multi-Plex cytokine assays (4)
(Bio-Rad, Hercules, CA). Groups of five C57BL/6 mice were infected i.p. with
5  105 cells of either the wild type or the virB mutant, and serum was obtained
from the saphenous vein at days 1, 4, and 7 postinfection. Cytokine detection was
performed according to the instructions provided by the kit’s manufacturer.
Briefly, serum was filtered twice through a 0.2-m filter and then diluted 1:3 in
Multi-Plex sample diluent buffer, added to the plate, and incubated at room
temperature for 30 min. The samples were washed several times, and 25 l of
the detection antibody solution was added to each well. Washes were mon-
itored by incubation at room temperature for 30 min. The samples were
washed, and 50 l of streptavidin-phycoerythrin was added and incubated at
room temperature for 10 min. The samples were washed and resuspended in
125 l of assay buffer (proprietary formula) and read using the Luminex 100
instrument (Bio-Rad).
For the detection of specific cytokines in the spleen, groups of five C57BL/6
mice were infected i.p. with 5  105 cells of either wild-type or virB mutant
B. abortus, and spleens were obtained at days 1, 4, and 7 postinfection.
Spleens were homogenized in 3 ml of PBS and passed through a 100-m cell
strainer. The cells were centrifuged for 10 min at 1,000 rpm. The supernatant
was passed twice through a 0.2-mm filter and cultured to ensure that no viable
bacteria were present. Cytokines were concentrated by using Millipore 5K
filter devices and stored at 80°C. Cytokine detection was performed as
described above.
ELISA. The presence of antibody specific for Brucella abortus in the serum
samples from 10 C57BL/6 mice infected with B. abortus 2308 and 10 mice
infected with the B. abortus virB mutant was determined by indirect enzyme-
linked immunosorbent assay (ELISA). MaxiSorp plates from Qiagen (Valencia,
CA) were coated with 100 l formalin-killed whole B. abortus cells (1 g/ml) in
carbonate buffer (pH 9.6), and plates were incubated at 4°C overnight. After
washing with PBS and 0.05% Tween 20, the serum samples were diluted 1:100 in
PBS containing 1% bovine serum albumin and incubated at room temperature
for 1 h. After washing with PBS and 0.05% Tween 20, the reactivity was mea-
sured using horseradish peroxidase-conjugated anti-mouse immunoglobulin M
(IgM), IgG, IgG1, IgG2a, or IgG3 (1:1,000; BD Pharmingen, San Diego, CA) by
incubating the plates at 37°C for 1 h. The reaction was developed with Sigma Fast
o-phenylenediamine dihydrochloride tablet sets. The resulting color was read at
410 nm with an ELISA microplate reader (MR5000; Dynatech). Data points are
the averages of duplicate dilutions, with each measurement being performed
twice.
RNA isolation. RNA was isolated using Tri reagent (Molecular Research
Centre, Inc., Cincinnati, OH). Spleen samples were homogenized in 1 ml of Tri
reagent and incubated for 5 min at room temperature. RNA was extracted by
adding 0.2 ml of chloroform and centrifuging the samples at 10,000 rpm for 15
min at 4°C. RNA was precipitated with 0.5 ml of isopropanol and resuspended
in H2O.
cDNA. One microgram of RNA was transcribed to cDNA using TaqMan
reverse transcription reagents (Applied Biosystems, Branchburg, NJ). The RNA
was mixed with a solution containing 5 l of 10 buffer, 11 l of 20 mM MgCl2,
10 l of deoxynucleoside triphosphates, 2.5 l of random hexamers, 1 l of
reverse transcriptase, and H2O in a final volume of 50 l. Samples were incu-
bated at 25°C for 10 min, followed by reverse transcription at 48°C for 30 min and
inactivation at 95°C for 5 min.
Real-time PCR. Reverse-transcribed cDNA was amplified with previously
reported primer sets (26) for mouse IFN- (forward primer TCA AGT GGC
ATA GAT GTG GAA GAA and reverse primer TGG CTC TGC AGG ATT
TTC ATG) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (forward
primer TGT AGA CCA TGT AGT TGA GGT CA and reverse primer AGG
TCG GTG TGA ACG GAT TTG) using Sybr green PCR master mix (Applied
Biosystems) and an ABI Prism 7900HT detection system (Applied Biosystems)
according to the manufacturer’s instructions. Induction of mRNA was deter-
mined from the threshold cycle (CT) values normalized for GAPDH expression
and then normalized to the value derived from the naive controls (23).
Intracellular cytokine staining. Intracellular staining for IFN- was performed
in splenocytes from groups of four C57BL/6 mice infected for 3 days with B.
abortus 2308 or a virB mutant. Splenocytes from each mouse were analyzed
individually using four-color flow cytometry. Briefly, after passing the spleen cells
through a 100-m cell strainer and treating the samples with ACK buffer (0.15
M NH4Cl, 1.0 mM KHCO3, 0.1 mM Na2EDTA [pH 7.2]) to lyse red blood cells,
splenocytes were washed with PBS (Gibco) containing 1% bovine serum albumin
(fluorescence-activated cell sorter [FACS] buffer). Cells were incubated for 6 h
in RPMI 1640–5% fetal bovine serum with 10 g/ml brefeldin A (Sigma). Cells
were stained individually or with a cocktail of Pacific Blue-conjugated rat anti-
mouse CD4 (L3T4), Alexa Fluor 700-conjugated rat anti-mouse CD8a (Ly-2),
and allophycocyanin II-Alexa Fluor 750 rat anti-mouse CD3e (eBioscience). The
cells were washed with FACS buffer and fixed with 4% formaldehyde for 30 min
at 4°C, followed by permeabilization for 30 min using a saponin-based buffer and
staining with phycoerythrin-conjugated anti-mouse IFN- for 30 min at 4°C.
Finally, samples were washed in FACS buffer containing saponin. Flow cytom-
etry analysis was performed using an LSRII apparatus (Becton Dickinson, San
Diego, CA), and data were collected for over 1 million cells/mouse. The CD3
cells were gated (R1) based on side scatter and CD3 expression. CD4 or CD8
T cells were gated (R2) based on CD3 expression and CD4 or CD8 expression,
respectively.
Statistical analysis. For the determination of statistical significance between
experimental groups, a Student’s t test was performed on the data after loga-
rithmic conversion. A P value of 0.05 was considered to be significant.
RESULTS
The T4SS mutant and the wild type elicit different antibody
responses in infected mice. To compare host responses to
wild-type B. abortus and a virB mutant, anti-B. abortus IgG
levels in serum from infected mice were measured by ELISA.
The results of this experiment (Fig. 1A) revealed that between
days 7 and 21, the virB mutant elicited a higher B. abortus-
specific IgG response than strain 2308, while after day 56, mice
infected with wild-type B. abortus exhibited higher IgG titers.
This trend was also observed when IgM was assayed in the
same serum samples (data not shown). The differences in titer
early during infection may reflect increased killing and presen-
tation of antigen from the virB mutant, which started to be
cleared from spleens of infected mice by 5 days after infection,
while CFU of the wild-type strain did not decline (31). To
determine whether these IgG responses are qualitatively sim-
ilar, we assayed the same serum samples for IgG1, IgG2a, and
IgG3 isotypes. Both strains elicited similar levels of IgG1 (Fig.
1B) and IgG3 (Fig. 1D), but levels of IgG2a (Fig. 1C) were
significantly higher in mice infected with B. abortus 2308 be-
tween 35 and 70 days postinfection. In an identical experiment
performed using BALB/c mice (data not shown), we obtained
the same results, showing that this difference is not related to
differences between the two mouse strains in their responses to
Brucella infection (25).
The virB mutant elicits reduced levels of circulating IFN-
and IL-12 in comparison with those of wild-type B. abortus. In
order to determine whether the higher levels of IgG2a elicited
by wild-type B. abortus reflected a greater Th1 polarization of
the early immune response, we determined the levels of the
Th1-associated cytokines IFN- and IL-12 after infection with
wild-type B. abortus or the virB mutant. For these experiments,
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mice were infected with either wild-type B. abortus or the virB
mutant, and serum was obtained at days 1, 4, and 7 postinfec-
tion. The detection of IFN- and IL-12p40 was performed
using BioPlex cytokine assays (Fig. 2). Since the cytokine levels
in naive serum varied among mice, the increase in the cytokine
concentration in infected serum samples over that in unin-
fected serum samples was calculated (Fig. 2). Results of the
cytokine assays showed that on days 4 and 7 postinfection,
levels of IFN- and IL-12p40 remained unchanged in the sera
of mice infected with B. abortus virB, whereas in mice infected
with the B. abortus wild-type strain, the levels of IL-12p40 and
IFN- increased significantly above preinfection levels.
Splenocytes of mice infected with the Brucella wild-type
strain produce higher levels of IFN- than do splenocytes of
mice infected with the T4SS mutant. Since B. abortus grows
and persists in tissues of the reticuloendothelial system, we
determined whether the difference in the level of circulating
IFN- correlates with changes in IFN- production in splenic
tissue when the CFU levels of 2308 and the virB mutant are
similar. RNA from spleens isolated from mice infected with B.
abortus 2308 or the virB mutant was used to quantify IFN-
transcripts by quantitative real-time PCR. The results shown in
Fig. 3A are normalized to levels of GAPDH and to levels in
uninfected mice using the 2CT formula. Figure 3B (bottom)
shows increases in IFN- protein levels measured by a BioPlex
assay in concentrated supernatants of spleen homogenates.
Significantly greater increases in both IFN- transcripts and
protein levels were observed at day 4 postinfection in mice
infected with B. abortus 2308 than in mice infected with the
virB mutant, which is in agreement with the levels of IFN-
measured in the serum (Fig. 2).
Splenic CD4 T cells, but not CD8 T cells, produce more
IFN- when mice are infected with wild-type B. abortus than
when they are infected with the virB mutant. We decided to
determine the main source of IFN- in splenic T cells after
infection with wild-type Brucella or the virB mutant (Fig. 4 and
5). Three days after infection, when the bacterial burdens of
wild-type B. abortus and the virB mutant were similar (31, 32;
data not shown), mice infected with wild-type B. abortus had
more numerous IFN--producing CD4 T cells (9.7% 
0.6%) than did virB mutant-infected mice (2.3%  0.5%) (Fig.
6). However, no difference in the frequencies of IFN--pro-
mutant
FIG. 1. Measurement of antibody levels in sera from mice infected
with B. abortus 2308 or the virB mutant by ELISA. Samples from
groups of 10 mice inoculated i.p. with 5  105 cells of either B. abortus
2308 or the virB mutant were taken at different times postinoculation.
The significance of differences between arithmetic means of data for
wild-type and mutant mice at each time point was determined using a
Student’s t test. Asterisks indicate significant differences between im-
munoglobulin levels in mice infected with 2308 and those in mice
infected with the virB mutant (P  0.05).
mutant
FIG. 2. Quantification of cytokine levels in sera of mice infected
with B. abortus 2308 or the virB mutant. Samples from groups of 10
mice infected i.p. with either B. abortus 2308 or the virB mutant were
taken at different times postinoculation, and cytokine concentrations
were determined by Multi-Plex assays. Data shown are increases in
cytokine concentrations over preinfection levels. The significance of
differences for wild-type and mutant mice at each time point was
determined using a paired Student’s t test. Error bars represent stan-
dard deviations. Asterisks indicate significant differences between the
wild type and the mutant (P  0.05).
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ducing CD8 T cells in wild-type and mutant-infected mice
was observed (2.7%  0.6% for 2308 and 2.6%  0.5% for the
virB mutant) (Fig. 6). This result shows that CD4 T cells are
the source of increased levels of IFN- elicited by B. abortus
and that infection with the virB mutant elicits reduced IFN-
production by splenic CD4 T cells.
DISCUSSION
This study was undertaken to investigate the in vivo effects of
the B. abortus T4SS on the host response to infection. We
showed previously that during the infection of mice with B.
abortus wild-type isolate 2308 and its isogenic virB mutant,
both strains are present in similar numbers for the first 5 days
postinfection (31). By 5 days postinfection, colonization of the
spleen by the T4SS mutant starts to decrease relative to that of
the wild-type, which persists at a constant level (31). The find-
ing that both the virB mutant and the wild type are initially able
to colonize the spleen at similar levels following i.p. inoculation
suggests that during the first few days after infection, the virB
mutant is able to resist immune clearance as well as does
wild-type B. abortus. However, despite equal survival rates in
tissues during this early period (3 to 4 days) after infection,
wild-type B. abortus and virB mutant B. abortus elicited very
different transcriptional responses in host splenocytes. While
infection with wild-type B. abortus resulted in the upregulation
of genes involved in inflammation and immunity, including
IFN- and genes induced by both IFN- and IFN-	/
, the virB
mutant used in the present study did not (32). To determine
whether these differences in early host transcriptional re-
sponses in the spleen correlate with differences in global im-
mune responses to both Brucella strains, we examined serum
mutant
FIG. 3. Quantification of IFN- levels in spleens of mice infected
with B. abortus 2308 or the virB mutant. (A) Transcript levels in spleens
from groups of five mice infected with either B. abortus 2308 (black
bars) or the virB mutant (white bars) were assayed by real-time reverse
transcription-PCR at different times postinoculation. Increases
(2CT) in transcript levels were calculated by normalizing CT values
for IFN- levels to CT values for GAPDH levels and to CT values for
IFN- levels measured in a group of mock-infected mice. (B) Cytokine
measurement of IFN- in splenic tissue by Multi-Plex assay was per-
formed with groups of five mice infected with either B. abortus 2308 or
the virB mutant at different times postinoculation. Data shown are
increases in cytokine concentrations over preinfection levels. The sig-
nificance of differences for wild-type and mutant mice at each time
point was determined using a paired Student’s t test. Error bars rep-
resent standard deviations. Asterisks indicate significant differences
between the wild type and the mutant (P 0.05). Results shown at the
top and bottom are from two independent experiments.
FIG. 4. IFN--producing CD4 T cells in spleens of mice after infection with B. abortus 2308 or the virB mutant. C57BL/6 mice (four mice per
group) were injected i.p. with PBS or 5 105 CFU of B. abortus 2308 or the virB mutant. Mice were sacrificed 3 days after infection, and splenocytes
were stained with a cocktail of Pacific Blue-conjugated anti-mouse CD4 (L3T4), Alexa Fluor 700-conjugated anti-mouse CD8a (Ly-2), APC-Alexa
Fluor 750 anti-mouse CD3e, and phycoerythrin-conjugated anti-mouse IFN-. One million cells/sample were acquired with an LSRII apparatus.
Numbers indicate the percentages of cells in each gate. Data for one mouse per group are shown as a representative of the group. SSC, side scatter.
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antibody and cytokine responses to wild-type B. abortus and
the T4SS mutant.
In line with previous reports, infection with wild-type B.
abortus preferentially elicited IgG2a, which is indicative of a
Th1-type response (41). Interestingly, the increase in the level
of IgG2a in sera of mice infected with the virB mutant over
levels in sera of uninfected mice was only modest (Fig. 1).
There are two possible explanations for this difference: one is
a lack of antigen to stimulate the immune response in mice
infected with the virB mutant, as by 56 days, very few of the virB
mutant bacteria remained in the spleen (17, 31). Alternatively,
wild-type B. abortus and the virB mutant could elicit different
responses early during infection that could influence later de-
velopment of different antibody isotype profiles. To test the
second idea, we compared serum cytokine profiles elicited by
infection with B. abortus 2308 and those elicited by infection
with the virB mutant at 3 to 4 days postinfection, when similar
numbers of both strains were present in the spleen (31). In
agreement with previously published reports (13, 14, 37, 44),
the levels of IL-12p40 and IFN- increased significantly above
preinfection levels in mice infected with wild-type B. abortus.
The virB mutant did not elicit IL-12 production, which is re-
quired for the stimulation of IFN- production and Th1 po-
larization (19), and also did not elicit IFN- production. We
did not detect increases in serum levels of IL-4 (not shown),
which would be indicative of Th2 polarization (40), in mice
infected with either B. abortus strain. The weak Th1 polariza-
tion elicited by the virB mutant may contribute to its reduced
protective properties as a vaccine compared with other atten-
uated strains of Brucella spp. (20, 21).
The cytokines present during T-cell responses influence the
differentiation of Th cells into Th1 cells, which produce IFN-
and IL-2, thereby stimulating cell-mediated responses, or Th2
cells, which produce IL-4, IL-5, IL-6, and IL-10 and mediate
humoral responses. Although differences in methodology
make it difficult to compare these results with those from
previously published studies, the trend that we observed is in
line with previous reports in which cytokine production could
be elicited in splenocytes from B. abortus-infected mice by ex
vivo stimulation with B. abortus antigens (18, 25, 27).
Effectors secreted by the T4SS play important roles in the
interaction of bacterial pathogens with their hosts, and a num-
ber of them interfere with the immune response to infection
(16, 30, 34, 36, 42). Furthermore, in Helicobacter pylori and
Legionella pneumophila, there is evidence for the T4SS-medi-
ated release of peptidoglycan (42) and flagellin (24, 29), re-
spectively, into infected cells, and therefore, the T4SS-depen-
dent induction of IFN- and IL-12 could result from either the
FIG. 5. IFN--producing CD8 T cells in spleens of mice after infection with B. abortus 2308 or the virB mutant. C57BL/6 mice (four mice per
group) were injected i.p. with PBS or 5  105 CFU of B. abortus 2308 or the virB mutant and sacrificed 3 days after infection. Splenocytes were
stained as described in the legend of Fig. 4. One million cells/sample were acquired with an LSRII apparatus. Numbers indicate the percentages
of cells in each gate. Data for one mouse per group are shown as a representative of the group. SSC, side scatter.
mutant
FIG. 6. Percentage of splenic CD4 T cells or CD8 T cells secret-
ing IFN- after infection with B. abortus 2308 or the virB mutant.
C57BL/6 mice (four mice per group) were injected i.p. with PBS or 5
105 CFU of B. abortus 2308 or the virB mutant. Mice were sacrificed 3
days after infection, and cells/mouse were stained for IFN--producing
cells. One million cells/sample were acquired with an LSRII apparatus.
The asterisk represents statistical significance determined using a Stu-
dent’s t test on data after logarithmic conversion.
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injection of effectors or the release of pathogen-associated
molecular patterns into the host cell cytosol. Once type IV
secreted Brucella molecules have been identified, it will be
possible to determine whether they act directly or indirectly to
trigger the T4SS-dependent host responses observed in this
study. In summary, results presented here suggest that the
T4SS is required to elicit early differences in cytokine re-
sponses to wild-type B. abortus and the virB mutant that con-
tribute to the Th1 polarization of the immune response.
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